Skip to main content

Table 3 OR and 95% CI of AIP Trajectories on DKD and DR in the T2D participants

From: Impact of baseline and trajectory of the atherogenic index of plasma on incident diabetic kidney disease and retinopathy in participants with type 2 diabetes: a longitudinal cohort study

AIP Trajectory

N (%)

Model 1

Model 2

Model 3

OR (95% CI)

P

OR (95% CI)

P

OR (95% CI)

P

DKD

       

Low

834(31.4%)

Reference

 

Reference

 

Reference

 

Median

1332(50.2%)

1.69(1.36,2.10)

< 0.001

1.80(1.44,2.27)

< 0.001

1.84(1.46,2.32)

< 0.001

High

486(18.3%)

1.74(1.33,2.28)

< 0.001

2.18(1.63,2.93)

< 0.001

2.17(1.62,2.91)

< 0.001

DR

       

Low

982(31.0%)

Reference

 

Reference

 

Reference

 

Median

1547(48.8%)

1.01(0.72,1.42)

0.966

1.08(0.75,1.55)

0.691

1.09(0.76,1.57)

0.653

High

641(20.2%)

0.78(0.49,1.22)

0.287

0.85(0.51,1.38)

0.515

0.84(0.51,1.37)

0.496

  1. Model 1: Crude model; Model 2: Adjusted for age, sex, HbA1c, duration of diabetes, BMI, SBP, ideal smoking, drinking; Model 3: Adjusted for covariables in model 2 plus LDL-C. DR refers to referable DR. Abbreviations: OR Odds ratio, CI Confidence interval, AIP atherogenic index of plasma, DKD diabetic kidney disease, DR diabetic retinopathy, T2D type 2 diabetes
Back to article page

Lipids in Health and Disease

ISSN: 1476-511X